SCHEMBL8360822

SCHEMBL8360822

O=C(c1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12)C1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 2/20 0.37
MAPT P10636 3/20 0.37
RXFP1 Q9HBX9 2/20 0.37
HPGD P15428 1/20 0.35
CNR2 P34972 1/20 0.34
PIK3CA P42336 1/20 0.34
PRKDC P78527 1/20 0.34
PDE11A Q9HCR9 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK10 P53779 1/20 0.33
MAPK14 Q16539 1/20 0.33
GRM5 P41594 1/20 0.33
TP53 P04637 1/20 0.33
SLC5A1 P13866 3/20 0.33
CDK4 P11802 2/20 0.33
CCND1 P24385 2/20 0.33
CCND2 P30279 2/20 0.33
CCND3 P30281 2/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287991 0.84 GAA (0.39) CSF1RMAPTHPGDPDE11ACDK4
SCHEMBL8287258 0.83 GRM5 (0.45) CSF1RMAPTHPGDGRM5ALDH1A1
SCHEMBL8287253 0.83 RIPK1 (0.43) MAPTRXFP1CNR2MAPK14
SCHEMBL8287262 0.82 HSD11B1 (0.46) MAPTRXFP1HPGDPDE11ASLC5A1
SCHEMBL8360854 0.81 MAPK14 (0.38) MAPTHPGDPDE11AMAPK14CDK4
SCHEMBL8287257 0.81 RAB9A (0.40) MAPTHPGDTP53ALDH1A1SMN1; SMN2
SCHEMBL8361774 0.81 RIPK1 (0.42) CNR2MAPK14ALDH1A1
SCHEMBL8287277 0.80 AOC3 (0.39) MAPTRXFP1PDE11ATP53CDK4
SCHEMBL8362709 0.80 PDE11A (0.39) CSF1RMAPTHPGDPDE11ATP53
SCHEMBL8287252 0.80 CXCR2 (0.37) CSF1RMAPTHPGDPDE11ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed